Skip to content

TLX - Telix Pharmaceuticals Ltd - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchT

Telix Pharmaceuticals Limited

TLX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

T

TLXTelix Pharmaceuticals Limited

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $12.60
52-wk low: $6.28
Prev close: $8.91
Mkt cap: $4.11B
Fwd P/E: 294.1x
Beta: 0.60

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$10.4M

MW
Marshall Wace
Q2 2026 13F
$2.2M
position
SC
Schonfeld
Steven Schonfeld · Q1 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -0.9%
Forward P/E: 294.12
Market cap: $4.1B

Valuation

P/S5.11
P/B9.69

Quality

Operating margin1.9%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: TLX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $4.11B
Beta: 0.60

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

5.1x

P/B

9.7x

Profit margin

-0.9%

Op margin

+1.9%

ROE

-1.9%

$334K

position

CI

Citadel

Ken Griffin · Q4 2025 13F

$172K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for TLX

No recent insider trade
No recent Congress trade
No recent market-voice mention

The latest quarter is still settling.

A verdict appears once the reported figure is final

Next report

What the street expects next

-1.9%

ROA1.1%

Growth

Beta0.60